Alzheimers Treatment

A look at life science innovation brought on by physician-biopharm tech hybrids

In this series, Dialogues+ is taking a look at innovation brought about through collaborations between physicians and biopharmaceutical/medical technology companies. Today, we look to potential future innovations and recent developments from the National Institutes of Health. Accelerating Medicines Partnership In February 2014, the National Institutes of Health (NIH) announced a new public-private partnership, the Accelerating […]

By Jon Tripp

Daily

J&J takes an early interest in biotech startup Alector’s approach to Alzheimer’s treatment

In another move to potentially beef up its Alzheimer’s pipeline, Johnson & Johnson has struck a drug development deal with one of the companies located at its innovation lab in San Francisco. J&J’s Innovation Center and San Francisco drug startup Alector announced today a deal under which Janssen will fund early R&D efforts for one […]

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

Devices & Diagnostics

In Case You Missed It: Top 10 stories from January on MedCity News

Take a look at the most read stories on MedCity News in January. You may have missed news on startups, medical innovations and new healthcare mobile apps.

By Amanda Harnocz

Hospitals

Clever Facebook campaign uses Photoshop + fake events to create Alzheimer’s experience

It was a month-long campaign to give average people a glimpse into what it's like to have Alheimer's disease — if only for a moment.

By Amanda Harnocz

Daily

In gamification milestone, Pfizer will assess video game in clinical trial for Alzheimer’s disease

In a move that could have a significant impact on how pharmaceutical companies view gamification, Pfizer (NYSE: PFE) has agreed to test the use of a mobile video game from Akili Interactive Labs to detect early signs of Alzheimer’s disease. The goal of the trial is to evaluate Akili’s game as a biomarker for potential […]

By Stephanie Baum

Pharma

One healthcare market that’s not growing quickly: Alzheimer’s disease drugs

3D printing in medicine is “skyrocketing.” Diabetes drugs comprise a huge market already and are poised for “strong growth” over the next 10 years. But a new market report is the latest in a slew of analyses forecasting an Alzheimer’s treatment market that, unlike many other healthcare markets, is on the decline — at least […]

Pharma

Janssen turns to Evotec for help discovering new targets and drugs for Alzheimer’s disease

Despite a major setback last summer when its promising drug bapineuzumab failed in late-stage clinical trials, Janssen Pharmaceuticals is looking to beef up its Alzheimer’s disease drug pipeline in a new deal with Evotec AG. Drug discovery company Evotec has a proprietary database of genes that are dysregulated in Alzheimer’s patients, as discovered in the […]

Health IT

3 neat ways to participate in crowdsourced cancer and Alzheimer’s disease research

Thanks to technology and the changing culture of medicine, those of us who don’t have thousands of dollars to donate to medical research have easier ways to contribute. Instead of money, we can donate our knowledge and our data. Crowdsourcing has tremendous potential in speeding up and broadening the scope of medical research, and the […]

Pharma

Startup Alzheon’s proposal for Alzheimer’s drug success adds new science to old, failed trials

From a commercial perspective, the last few decades of Alzheimer’s drug development have largely been a wash of promising disease-altering drugs failing to demonstrate efficacy in late-stage trials. For startup Alzheon, though, those failures have left behind a trail of valuable clinical and biomarker data that it thinks could lead to hidden treasure. Alzheon launched […]

Policy

Close look at 23andMe founder and what genetic testing means for adoptive parents

What began as an assignment to investigate and profile 23andMe Founder and CEO Anne Wojcicki took a personal turn for one adoptive parent and Fast Company contributor. In this article, a writer using the pseudonym Elizabeth Murphy examines her decision to get a spit-kit for herself and her daughter, a young child she adopted from […]

By Lindsey Alexander

Health Services

Maximize Revenue and Patient Care with Strategic Weight Loss Management

We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.

By Build My Health and MedCity News

MedCity Influencers

Obesity: A Risk Factor for Alzheimer’s

This post is part of ongoing coverage of Cleveland Clinic’s 2013 Medical Innovation Summit: Finding Balance through Innovation. Obesity, Diabetes & the Metabolic Crisis. Much of the current research of Alzheimer’s disease is conducted in patients who are already in cognitive decline. Also, too little research is being conducted on the long-term impact that chronic […]

Top Story

Want to solve your men’s health issue? Grow a mustache, join the Movember movement

Doctor Mike Evans’ Youtube Channel is one of my favorites. Watching “23 1/2 hours” changed my perspective on how I should be treating my body. Now, he and Movember CEO Adam Garone (TED Talk here) have created a video to promote men’s health, facial hair and Movember. This November, it asks men to find ways […]

By Lindsey Alexander

Health IT

NeuroTrack’s computer test for Alzheimer’s wins over Founders Fund, Social+Capital Partnership

What if a simple computer test administered in a doctor’s office could foretell which seniors would develop Alzheimer’s disease down the road? Startup NeuroTrack is working toward that, and now a few notable investors have joined in. NeuroTrack Technologies said that it’s raised $2 million in a Series A round led by Peter Thiel’s Founders […]

Pharma

Neuro drug developer iPierian nets $30M, spins off new company for rare disease R&D program

Rather than leveraging stem cells for therapeutic use, iPierian Inc. has been using them to create disease models with which is can screen and develop new drugs. Now, with $30 million it’s just collected from investors, iPierian Inc. plans to split two distinct R&D programs that have emerged from those techniques into different companies. Some […]

Devices & Diagnostics

Navidea’s Alzheimer’s imaging agent moves into Phase 3 with Siemens deal, SBIR grant

Navidea Biopharmaceuticals (NYSE:NAVB) is getting some financial support from the NIH for its Alzheimer’s diagnostic technology as it advances into Phase 3 development. The National Institute of Aging awarded up to $1.8 million for a late-stage clinical trial of the Navidea’s PET beta-amyloid imaging agent, the company said. NAV4694 is designed to help clinicians detect […]